Target intelligence / Profile preview

High mobility group nucleosomal binding domain 2 pseudogene 30 (HMGN2P30)

Target
HMGN2P30
Molecular classification
Pseudogene, Non-coding DNA segment
01

Overview

High mobility group nucleosomal binding domain 2 pseudogene 30 (HMGN2P30) is a processed pseudogene in the human genome that shares high sequence similarity to the functional HMGN2 gene, which encodes a chromatin-associated protein involved in nucleosome binding[3][5][2]. Pseudogenes like HMGN2P30 do not encode functional proteins due to mutations, frameshifts, or premature stop codons preventing translation[2][9]. While traditionally considered nonfunctional "junk DNA," emerging evidence suggests some pseudogenes may participate in the regulation of gene expression by acting as decoys for regulatory RNAs or by modulating transcript stability[7][9]. However, there are no direct therapeutic, biomarker, or safety implications for HMGN2P30, and it is not considered a druggable or disease-associated target.

02

Biological functions

May have regulatory roles, such as acting as a decoy for miRNAs, modulating expression of related genes, or producing noncoding RNAsDoes not have direct protein function
03

Disease associations

Potential indirect regulatory influence on gene networks, but no direct disease association identified for HMGN2P30

Beyond the preview

Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 30 (HMGN2P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 30 (HMGN2P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call